DanielEricFurstMD

Rheumatology • Inglewood, CA

Professor, Medicine, UCLA School of Medicine

Join to view full profile

Dr. Furst is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Furst's full profile

Already have an account?

Office
575 E Hardy St Ste 321
Inglewood, CA 90301
Phone+1 310-297-5812

Fax+1 310-943-2707

Education & Training

University of California (San Francisco)Fellowship, Rheumatology, 1975 - 1977
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1973 - 1975
Johns Hopkins UniversityResidency, Internal Medicine, 1968 - 1970
Johns Hopkins University School of MedicineClass of 1968

Certifications & Licensure

CA State Medical License 2002 - 2025
WA State Medical License 1992 - 2024
NJ State Medical License 1987 - 1993
IA State Medical License 1982 - 1992
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma Start of enrollment: 2003 Oct 01
Completed
Phase 3
Scleroderma: Cyclophosphamide or Transplantation Start of enrollment: 2005 Jun 01
Completed
Phase 2, Phase 3
Long-term Observation of Patients With Early Rheumatoid Arthritis Start of enrollment: 1993 Jan 01
Completed
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
Completed
A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis Start of enrollment: 2007 Aug 01
Completed
Phase 1, Phase 2
SCOT Scleroderma Treatment Alternative Registry (STAR Registry) Start of enrollment: 2005 Jun 01
Completed
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) Start of enrollment: 2009 Sep 01
Completed
Phase 2
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan Start of enrollment: 2009 Mar 01
Completed
Phase 4
Scleroderma Treatment With Autologous Transplant (STAT) Study Start of enrollment: 2011 Sep 15
Active, not recruiting
Phase 2
Morbidity and Mortality Follow Up for the Scleroderma Lung Study Start of enrollment: 2012 Jul 01
Completed
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor Start of enrollment: 2013 Jul 01
Completed
Phase 2
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Start of enrollment: 2013 Oct 01
Completed
Phase 2
Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background Start of enrollment: 2014 Jul 01
Withdrawn
Not Applicable
Join now to see all

Publications & Presentations

PubMed

22 citations
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.
Linda Kwakkenbos, Brett D Thombs, Dinesh Khanna, Marie-Eve Carrier, Murray Baron
Rheumatology. 2017-08-01
17 citations
Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study
Sarah D. Mills, Rina S. Fox, Erin L. Merz, Philip J. Clements, Suzanne Kafaja
The Journal of Rheumatology. 2015-09-01
674 citations
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka, Jaap Fransen, Jérôme Avouac, Mike O Becker, Agnieszka Kulak
Annals of the Rheumatic Diseases. 2015-06-01

Journal Articles

Long‐Term Safety of Rituximab in Rheumatoid Arthritis: Analysis from the SUNSTONE Registry
Kenneth Saag, Daniel E Furst, Kevin L Winthrop, Arthritis Care & Research
The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma Cohorts
Daniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results from the Open-Label Period of a Phase II Randomised Controlled Trial (faSScinate)
Dinesh Khanna, Daniel Eric Furst, Emergency Medicine Journal
Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients with Pulmonary Involvement
Keith M Sullivan, Ankoor Shah, Daniel E Furst, Stefanie Sarantopoulos, Arthritis & Rheumatology
Join now to see all

Lectures

Clinical Triad: Rheumatology: Early Diagnoses You Don't Want to Miss
2019 ACP Internal Medicine Meeting, Philadelphia - 4/11/2019
High-Frequency Ultrasound of the Skin in Systemic Sclerosis: An Exploratory Study to Examine Correlation with Disease Activity and to Define the Minimally Detectable D...
Global Academy for Medical Education (Elsevier), Las Vegas, Nevada - 9/20/2013
Practical Suggestions on Intravenous Iloprost in Raynaud's Phenomenon and Digital Ulcer Secondary to Systemic Sclerosis: Systematic Literature Review and Expert Consensus
Global Academy for Medical Education (Elsevier), Newport Beach, California - 9/28/2012
6th Annual Perspectives in Rheumatic Diseases
Global Academy for Medical Education (Elsevier), Las Vegas, Nevada - 9/20/2013
6th Annual Perspectives In Rheumatic Diseases Conference Presented By Rheumatology News, Family Practice News & Internal Medicine News
Global Academy For Medical Education, Las Vegas, Nevada - 9/20/2013
6th Annual Perspectives In Rheumatic Diseases Conference Presented By Rheumatology News, Family Practice News & Internal Medicine News
Global Academy For Medical Education, Las Vegas, Nevada - 9/20/2013
Join now to see all

Other

High-Frequency Ultrasound of the Skin in Systemic Sclerosis: An Exploratory Study to Examine Correlation with Disease Activity and to Define the Minimally Detectable D...
Daniel Furst, MD, BioMed Central
https://www.doximity.com/articles/596b1106-d25d-43ba-b6f6-cb36588ec95a
UpToDate, Wolters Kluwer Health - 2012-04-18
High-Frequency Ultrasound of the Skin in Systemic Sclerosis: An Exploratory Study to Examine Correlation with Disease Activity and to Define the Minimally Detectable D...
Daniel Furst, MD, BioMed Central
https://www.doximity.com/articles/596b1106-d25d-43ba-b6f6-cb36588ec95a
UpToDate, Wolters Kluwer Health - 2012-12-04
Practical Suggestions on Intravenous Iloprost in Raynaud's Phenomenon and Digital Ulcer Secondary to Systemic Sclerosis: Systematic Literature Review and Expert Consensus
Daniel Furst, MD, Seminars in Arthritis & Rheumatism
https://www.doximity.com/articles/77f3eb9e-97ba-4506-a089-c6dab8de75b7
UpToDate, Wolters Kluwer Health - 2012-04-18
Practical Suggestions on Intravenous Iloprost in Raynaud's Phenomenon and Digital Ulcer Secondary to Systemic Sclerosis: Systematic Literature Review and Expert Consensus
Daniel Furst, MD, Seminars in Arthritis & Rheumatism
https://www.doximity.com/articles/77f3eb9e-97ba-4506-a089-c6dab8de75b7
UpToDate, Wolters Kluwer Health - 2013-04-08
Join now to see all

Press Mentions

AYUSH Ministry to Conduct World's First Multicentre Phase 3 Clinical Trial in Ayurveda for Rheumatoid ArthritisMarch 23rd, 2022
Philip J. Clements, MD, MPH, MACR, Is Recognized by Continental Who's WhoAugust 20th, 2020
Vascular Biomarkers Predict Pulmonary Hypertension in Systemic SclerosisApril 3rd, 2020
Join now to see all

Grant Support

Provisional Combined Response Index For Patients With Diffuse Systemic SclerosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2009
Oral Cyclophosphamide VS Oral Placebo In SSC AlveolitisNational Heart, Lung, And Blood Institute2001
Analysis Of Controlled Trial Of Chlorambucil Vs. PlaceboFood And Drug Administration1985–1986
Sodium Retaining Characteristics Of Carprofen And Indomethacin In ManNational Center For Research Resources1985
Salicylsalicylic Acid--Rheumatoid ArthritisNational Center For Research Resources1985

Professional Memberships

American College of Rheumatology - ACR
Member
American College of Radiology - ACR
Master Member